ABCB1 and acute lymphoblastic leukemia: Furthermore, the sensitivity of carfilzomib (CFZ)-resistant myeloma cell line AMO-CFZ [73] and acute lymphoblastic leukaemia (ALL) cell line HALO1 [74] to CFZ was recovered after knocking out ABCB1 using the CRISPR-Cas9 system.